News

"FDA approves Dymicron’s study of cervical artificial disc" was originally created and published by Medical Device Network, a ...
A new study published in the journal of Arthritis Care and Research revelaed that metabolic syndrome is associated with ...
Dymicron’s Triadyme-C artificial disc earned the FDA’s investigational device exemption approval, according to a July 10 news release. The IDE approval opens the door for a U.S. trial of the disc, ...
Dymicron®, a privately held medical device company pioneering advanced spinal technologies, today announced that the United ...
According to Credence Research, the global Spine Degenerative Disk Disease Treatment Market was valued at USD 22,272.2 ...
FibroBiologics Confirms Ability to Manufacture CybroCell™ for Degenerative Disc Disease and Cartilage Repair Programs from Existing CYWC628 Master Cell Bank Provided by GlobeNewswire Jul 9, 2025 ...
Spine tech developer Highridge Medical said it is commencing production "imminently" to launch the product later this year.